Yearly Archives: 2013

Four-year project on biomarker use in oncology generates 9 patent applications

The project, subsidised by Centre for the Development of Industrial Technology (CDTI), is one of the activities of the ONCOLÓGICA consortium, created four years ago by...

GynEC®-DX in a BCC Research forecasting report

BCC Research, a leading provider of market research since 1971, mentioned GynEC®-DX in its forecasting report on Therapies and Diagnostics for Uterine Cancer. This report HLC142A provides an...

GynEC®-DX clinical validation published in International Journal of Cancer

GynEC®-DX is an in vitro diagnostic test for the detection of endometrial cancer. The product was validated in a double blind, prospective, multicentre study involving...

GynEC®-DX launched in Spain

The first molecular diagnostic test for the detection of endometrial cancer developed by GEADIC Biotec AIE, joint venture between Oryzon Genomics & Reig Jofre,...